{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T15:08:47Z","timestamp":1794928127572,"version":"4.9.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,11,4]],"date-time":"2019-11-04T00:00:00Z","timestamp":1572825600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"GlaxoSmithKline Biologicals SA"},{"DOI":"10.13039\/100005624","name":"PATH Malaria Vaccine Initiative","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005624","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.vaccine.2019.10.077","type":"journal-article","created":{"date-parts":[[2019,11,7]],"date-time":"2019-11-07T09:00:49Z","timestamp":1573117249000},"page":"897-906","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Safety and immunogenicity of the RTS,S\/AS01 malaria vaccine in infants and children identified as HIV-infected during a randomized trial in sub-Saharan Africa"],"prefix":"10.1016","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9930-5143","authenticated-orcid":false,"given":"Lucas","family":"Otieno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yolanda","family":"Guerra Mendoza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Adjei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsiri","family":"Agbenyega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selidji Todagbe","family":"Agnandji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Aide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"Akoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Ansong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwaku Poku","family":"Asante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1236-849X","authenticated-orcid":false,"given":"James A","family":"Berkley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samwel","family":"Gesase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary J.","family":"Hamel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irving","family":"Hoffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6949-4203","authenticated-orcid":false,"given":"Seyram","family":"Kaali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Portia","family":"Kamthunzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Kariuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Kremsner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Lanaspa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand","family":"Lell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Lievens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Lusingu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anangisye","family":"Malabeja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nahya Salim","family":"Masoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali Takadir","family":"Mtoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Njuguna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Opokua","family":"Ofori-Anyinam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Godfrey Allan","family":"Otieno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Otieno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seth","family":"Owusu-Agyei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lode","family":"Schuerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1595-5152","authenticated-orcid":false,"given":"Hermann","family":"Sorgho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel","family":"Tanner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Halidou","family":"Tinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Innocent","family":"Valea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascale","family":"Vandoolaeghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jahit","family":"Sacarlal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Oneko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2019.10.077_b0005","unstructured":"World Health Organization. World Malaria Report 2018. Geneva: World Health Organization, https:\/\/www.who.int\/malaria\/publications\/world-malaria-report-2018\/report\/en\/; 2018 [accessed 1 April 2019]."},{"key":"10.1016\/j.vaccine.2019.10.077_b0010","unstructured":"Joint United Nations Programme on HIV\/AIDS (UNAIDS). UNAIDS data 2018, http:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/unaids-data-2018_en.pdf; 2018 [accessed 1 April 2019]."},{"key":"10.1016\/j.vaccine.2019.10.077_b0015","first-page":"123","article-title":"Malaria and HIV coinfection in sub-Saharan Africa: prevalence, impact, and treatment strategies","volume":"9","author":"Kwenti","year":"2018","journal-title":"Res Rep Trop Med"},{"key":"10.1016\/j.vaccine.2019.10.077_b0020","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000003205","article-title":"The effect of malaria and HIV co-infection on anemia: a meta-analysis","volume":"95","author":"Naing","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.vaccine.2019.10.077_b0025","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S1473-3099(11)70100-1","article-title":"Safety and efficacy of the RTS, S\/AS01E candidate malaria vaccine given with expanded-programme-on-immunisation vaccines: 19 month follow-up of a randomised, open-label, phase 2 trial","volume":"11","author":"Asante","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2019.10.077_b0030","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1056\/NEJMoa0807381","article-title":"Efficacy of RTS, S\/AS01E vaccine against malaria in children 5 to 17 months of age","volume":"359","author":"Bejon","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2019.10.077_b0035","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1056\/NEJMoa1102287","article-title":"First results of phase 3 trial of RTS, S\/AS01 malaria vaccine in African children","volume":"365","author":"RTSS Clinical Trials Partnership","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2019.10.077_b0040","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1056\/NEJMoa1208394","article-title":"A phase 3 trial of RTS, S\/AS01 malaria vaccine in African infants","volume":"367","author":"RTSS Clinical Trials Partnership","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2019.10.077_b0045","article-title":"Efficacy and safety of the RTS, S\/AS01 malaria vaccine during 18 months after vaccination: a phase 3 randomized, controlled trial in children and young infants at 11 African sites","volume":"11","author":"RTSS Clinical Trials Partnership","year":"2014","journal-title":"PLoS Med"},{"key":"10.1016\/j.vaccine.2019.10.077_b0050","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(15)60721-8","article-title":"Efficacy and safety of RTS, S\/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial","volume":"386","author":"RTSS Clinical Trials Partnership","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2019.10.077_b0055","unstructured":"European Medicines Agency. Committee for Medicinal Products for Human Use (CHMP) Summary of opinion, Mosquirix, http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Medicine_for_use_outside_EU\/2015\/07\/WC500190452.pdf; 2015 [accessed 4 October 2018]."},{"key":"10.1016\/j.vaccine.2019.10.077_b0060","first-page":"33","article-title":"Malaria vaccine: WHO position paper-January 2016","volume":"91","author":"World Health Organization","year":"2016","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2019.10.077_b0065","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/S1473-3099(16)30161-X","article-title":"Safety and immunogenicity of RTS, S\/AS01 malaria vaccine in infants and children with WHO stage 1 or 2 HIV disease: a randomised, double-blind, controlled trial","volume":"16","author":"Otieno","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2019.10.077_b0070","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1186\/s12936-017-2078-3","article-title":"Longitudinal estimation of Plasmodium falciparum prevalence in relation to malaria prevention measures in six sub-Saharan African countries","volume":"16","author":"Drakeley","year":"2017","journal-title":"Malar J"},{"key":"10.1016\/j.vaccine.2019.10.077_b0075","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/1475-2875-10-224","article-title":"Design of a phase III multicenter trial to evaluate the efficacy of the RTS, S\/AS01 malaria vaccine in children across diverse transmission settings in Africa","volume":"10","author":"Leach","year":"2011","journal-title":"Malar J"},{"key":"10.1016\/j.vaccine.2019.10.077_b0080","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1186\/1475-2875-10-222","article-title":"Statistical methodology for the evaluation of vaccine efficacy in a phase III multi-centre trial of the RTS, S\/AS01 malaria vaccine in African children","volume":"10","author":"Lievens","year":"2011","journal-title":"Malar J"},{"key":"10.1016\/j.vaccine.2019.10.077_b0085","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/1475-2875-10-223","article-title":"Development of standardized laboratory methods and quality processes for a phase III study of the RTS, S\/AS01 candidate malaria vaccine","volume":"10","author":"Swysen","year":"2011","journal-title":"Malar J"},{"key":"10.1016\/j.vaccine.2019.10.077_b0090","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/1475-2875-10-221","article-title":"Assessment of severe malaria in a multicenter, phase III, RTS, S\/AS01 malaria candidate vaccine trial: case definition, standardization of data collection and patient care","volume":"10","author":"Vekemans","year":"2011","journal-title":"Malar J"},{"key":"10.1016\/j.vaccine.2019.10.077_b0095","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1080\/14760584.2016.1236689","article-title":"The RTS, S\/AS01 malaria vaccine in children 5 to 17 months of age at first vaccination","volume":"15","author":"Vandoolaeghe","year":"2016","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2019.10.077_b0100","unstructured":"World Health Organization. Pocket book of Hospital care for children; Guidelines for the management of common illnesses with limited resources, http:\/\/whqlibdoc.who.int\/publications\/2005\/9241546700.pdf; 2005 [accessed 4 October 2018]."},{"key":"10.1016\/j.vaccine.2019.10.077_b0105","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.vaccine.2003.09.008","article-title":"Generalized convulsive seizure as an adverse event following immunization: case definition and guidelines for data collection, analysis, and presentation","volume":"22","author":"Bonhoeffer","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.10.077_b0110","first-page":"1","article-title":"Safety profile of the RTS, S\/AS01 malaria vaccine in infants and children: additional data from a phase III randomized controlled trial in sub-Saharan Africa","author":"Guerra Mendoza","year":"2019","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2019.10.077_b0115","unstructured":"World Health Organization. Verbal autopsy standards. Ascertaining and attributing cause of death, http:\/\/apps.who.int\/iris\/bitstream\/10665\/43764\/1\/9789241547215_eng.pdf; 2007 [accessed 4 October 2018]."},{"key":"10.1016\/j.vaccine.2019.10.077_b0120","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1186\/1475-2875-11-384","article-title":"Validation of an enzyme-linked immunosorbent assay for the quantification of human IgG directed against the repeat region of the circumsporozoite protein of the parasite Plasmodium falciparum","volume":"11","author":"Clement","year":"2012","journal-title":"Malar J"},{"key":"10.1016\/j.vaccine.2019.10.077_b0125","unstructured":"CIOMS. Management of Safety Information from Clinical Trials. Report of CIOMS Working Group VI, https:\/\/cioms.ch\/wp-content\/uploads\/2017\/01\/Mgment_Safety_Info.pdf; 2005 [accessed 4 October 2018]."},{"key":"10.1016\/j.vaccine.2019.10.077_b0130","doi-asserted-by":"crossref","first-page":"e00514","DOI":"10.1128\/mBio.00514-16","article-title":"RTS, S Malaria vaccine and increased mortality in girls","volume":"7","author":"Klein","year":"2016","journal-title":"MBio"},{"key":"10.1016\/j.vaccine.2019.10.077_b0135","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000005881","article-title":"Vaccination with 10-valent pneumococcal conjugate vaccine in infants according to HIV status","volume":"96","author":"Madhi","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.vaccine.2019.10.077_b0140","first-page":"61","article-title":"Immunization of children at risk of infection with human immunodeficiency virus","volume":"81","author":"Moss","year":"2003","journal-title":"Bull World Health Organ"},{"issue":"Suppl 3","key":"10.1016\/j.vaccine.2019.10.077_b0145","doi-asserted-by":"crossref","first-page":"C61","DOI":"10.1016\/j.vaccine.2012.02.040","article-title":"Immunising the HIV-infected child: a view from sub-Saharan Africa","volume":"30","author":"Mphahlele","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.10.077_b0150","unstructured":"World Health Organization Europe. Protocol 12. Immunization of people living with HIV\/AIDS and people at risk of HIV infection - Clinical protocol for the WHO European Region, http:\/\/www.euro.who.int\/__data\/assets\/pdf_file\/0004\/78502\/E90840_Chapter_12.pdf?ua=1. [accessed 2019 23 September]."},{"key":"10.1016\/j.vaccine.2019.10.077_b0155","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1586\/eri.11.167","article-title":"HIV and malaria interactions: where do we stand?","volume":"10","author":"Gonzalez","year":"2012","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.vaccine.2019.10.077_b0160","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1080\/14760584.2017.1307740","article-title":"Pneumococcal conjugate vaccine in HIV-infected and HIV-exposed, uninfected children","volume":"16","author":"Jallow","year":"2017","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2019.10.077_b0165","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1097\/00006454-199211120-00002","article-title":"Diarrhea among African children born to human immunodeficiency virus 1-infected mothers: clinical, microbiologic and epidemiologic features","volume":"11","author":"Pavia","year":"1992","journal-title":"Pediatr Infect Dis J"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2019.10.077_b0170","doi-asserted-by":"crossref","first-page":"A173","DOI":"10.1016\/j.vaccine.2011.08.004","article-title":"Five-year cohort study on the burden of hospitalisation for acute diarrhoeal disease in African HIV-infected and HIV-uninfected children: potential benefits of rotavirus vaccine","volume":"30","author":"Groome","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.10.077_b0175","doi-asserted-by":"crossref","first-page":"328","DOI":"10.3389\/fimmu.2018.00328","article-title":"The effect of human immunodeficiency virus and cytomegalovirus infection on infant responses to vaccines: a review","volume":"9","author":"Falconer","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2019.10.077_b0180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0175570","article-title":"Proportions of circulating follicular helper T cells are reduced and correlate with memory B cells in HIV-infected children","volume":"12","author":"Muema","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2019.10.077_b0185","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1182\/blood-2005-11-013383","article-title":"Loss of memory B cells impairs maintenance of long-term serologic memory during HIV-1 infection","volume":"108","author":"Titanji","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.vaccine.2019.10.077_b0190","unstructured":"World Health Organization. Pocket book of hospital care for children: Second edition. Guidelines for the management of common childhood illnesses, https:\/\/www.who.int\/maternal_child_adolescent\/documents\/child_hospital_care\/en\/; 2013 [accessed 3 May 2019]."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19314665?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19314665?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:39:24Z","timestamp":1759401564000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19314665"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S0264410X19314665"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.10.077","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and immunogenicity of the RTS,S\/AS01 malaria vaccine in infants and children identified as HIV-infected during a randomized trial in sub-Saharan Africa","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.10.077","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 GlaxoSmithKline Biologicals S.A. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}